CompletedNot Applicable

Changes InMPOD After Full-thickness Macular Hole Closure

Italy15 participantsStarted 2023-06-01

Plain-language summary

The notable increase in MPOD following successful surgery suggests its potential role as a valuable adjunctive biomarker associated with a good visual prognosis following this type of macular hole surgical interventions.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria:age older than 60 years * diagnosis of FTHM * absence of other ocular diseases, responsible for macular edema (retinal vein occlusion, diabetic retinopathy, age-related macular degeneration Exclusion Criteria: No diagnosis of pseudophakic cystoid macular oedema * previous treatment for pseudophakic cystoid macular oedema * presence of other ocular diseases, responsible for macular edema (retinal vein occlusion, diabetic retinopathy, age-related macular degeneration)

What they're measuring

MPOD After Full-thickness Macular Hole Closure (FTMH)

Timeframe: 6 months

MPOD and Macula hole: before and after surgery

Timeframe: six months

Trial details

NCT IDNCT06664515

SponsorFederico II University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07-01

View on ClinicalTrials.gov More Full Macular Hole trials